Mena Mani Inds. (531127)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹8.57 |
| Market Cap | ₹88.77 Cr |
| P/E Ratio | 0 |
| ROCE | 2.9% |
| ROE | 96.72% |
| Dividend Yield | 0% |
| Profit Growth | -84.21% |
| Debt/Equity | — |
| Sales Growth | 23.51% |
| 52-Week Range | ₹6.15 — ₹10.36 |
| Sector | Finance |
Strengths
- Sales growth of 23.51% shows the business is not shrinking at the top line.
- Latest quarterly sales of ₹6 Cr provide a base to monitor future recovery.
- Small market cap of ₹89 Cr leaves room for niche growth if capital is deployed wisely.
- ROE of 96.72% suggests the existing equity base is being worked hard, though quality is questionable.
Concerns
- Profit growth is -84.21% and latest quarter net profit is ₹0 Cr, leaving no earnings to support the valuation.
- ROCE of only 2.90% indicates very poor return on capital actually employed.
- Piotroski F-Score of 4/9 points to weak financial health.
- Book value, debt/equity, and promoter holding are unavailable, and P/E is meaningless at zero earnings.
AI Analysis
Looking at Mena Mani Inds., I am reminded that a business is only as good as its earning power. The price of ₹8.57 capitalizes the company at ₹89 Crore, but what do I actually get in return? Latest quarter sales are ₹6 Crore and net profit is roughly ₹0 Crore. Over the year, profit collapsed by 84.21% even while sales grew 23.51%. That tells me the company is expanding turnover without converting it into profits—perhaps due to weak pricing power, high costs, or provisioning in an NBFC. ROE of 96.72% looks seductive at first glance, but with ROCE of only 2.90%, the return on actual capital employed is poor. The high ROE is likely arithmetic from a thin equity base, not evidence of a durable franchise. The Piotroski F-Score of 4/9 reinforces my caution. There is no dividend, so my returns would depend entirely on future earnings. I cannot calculate book value, debt-to-equity, or promoter holding from the data given; as Graham would say, what is undisclosed cannot be trusted. The 52-week range of ₹6.15 to ₹10.36 shows a volatile, speculative stock, not a steady compounder. This is at best a turnaround candidate, not a stalwart. I need evidence of stable margins, positive net profit, and clean asset quality before I put a rupee in. Until then, I prefer to watch from the sidelines.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer